Regulatory T cell deficiencies in Crohn’s
disease and ulcerative colitis
A/Prof
Barbara Fazekas de St. Groth
T Cell
Biology Group
Centenary
Email: b.fazekas@centenary.usyd.edu.au
Phone: 9565
6137
The long term aim of our group is to
understand how the immune system chooses the appropriate response to mount
under each different circumstance. This choice involves interactions between dendritic cells and T cells, which are the focus of our
lab. A multitude of diseases, generally grouped under the heading autoimmune
diseases, result from inappropriate immune responses. These include juvenile diabetes, rheumatoid arthritis, thyroid disease, multiple
sclerosis, Crohn’s disease and ulcerative colitis.
Current treatments are only partially effective and have very significant side
effects. Our aim is to prevent such diseases and/or to cure them, rather than
providing long term treatments that do not effectively treat the underlying
condition.
We have recently discovered that one of the
ways regulatory T cells prevent autoimmune disease is by controlling the
expression of costimulatory molecules on dendritic cells. This led us to test whether patients with
inflammatory bowel disease had deficiencies in regulatory T cell numbers that
could have made them susceptible to disease. Our recent data has shown for the
first time that this is indeed the case. In several other autoimmune diseases,
the function of regulatory T cells may also be defective. We would like to test
this in our cohort of patients with Crohn’s disease
and ulcerative colitis.
Project Outline
Peripheral blood, lymph nodes and mucosa from
bowel biopsies are available from patients with inflammatory bowel disease who
attend the clinics of Prof Warwick Selby and Prof Michael Solomon at
1) Do regulatory T cells from patients
suppress as effectively as those from normal controls?
2) What are the molecules used by regulatory
T cells to control the function of dendritic cells?
We are currently performing gene chip analysis which is providing an array of
candidate molecules for testing in biochemical and functional assays.
Regulatory T cells also produce a number of soluble molecules that affect dendritic cell function and assays will be set up to
measure production of these molecules by regulatory T cells from patients and
controls.
Techniques
This project will give the student experience
in lymphocyte purification and labelling, tissue culture, flow cytometry, DNA microarrays,
bioinformatics, RT-PCR.